Clinical Research Directory
Browse clinical research sites, groups, and studies.
Imaging Biomarkers in Preclinical and Symptomatic AD
Sponsor: Tammie L. S. Benzinger, MD, PhD
Summary
The purpose of this research study is to evaluate adult children of parents with and without Alzheimer's disease which represent an ideal population for investigating the biological changes that precede the clinical onset of AD. The investigators will be imaging the brain to detect the presence of amyloid deposits (plaques in the brain). Amyloid is a protein that may be related to dementia of Alzheimer's disease (DAT).
Official title: Imaging Biomarkers in Preclinical and Symptomatic AD. (ACS PiB IND)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
375
Start Date
2021-06-08
Completion Date
2029-10
Last Updated
2025-08-07
Healthy Volunteers
No
Conditions
Interventions
[11C] Pittsburgh Compound-B (PIB)
Participants will receive a single intravenous bolus injection of 6.0 - 20.0 mCi (222-740 MBq) of the investigational radiotracer \[11C\] PIB. Participants will then undergo a \[11C\] PIB PET/CT scan conducted in the Center for Clinical Imaging Research (CCIR) facility.
Locations (1)
Washington University School of Medicine
St Louis, Missouri, United States